index - Institut de Recherche en Cancérologie de Montpellier

Bienvenue sur la collection HAL de l'Institut de Recherche en Cancérologie de Montpellier

Michalis Fragkos, Viviana Barra, Tom Egger, Benoit Bordignon, Delphine Lemacon, et al.. Dicer prevents genome instability in response to replication stress. Oncotarget, 2019, 10 (43), pp.4407-4423. ⟨10.18632/oncotarget.27034⟩. ⟨hal-04442048⟩
Léa Rubira, Charlotte Donzé, Juliette Fouillet, Benjamin Algudo, Pierre Olivier Kotzki, et al.. [68Ga]Ga-FAPI-46 synthesis on a GAIA® module system: thorough study of the automated radiolabeling reaction conditions. Applied Radiation and Isotopes, 2024, 206, pp.111211. ⟨10.1016/j.apradiso.2024.111211⟩. ⟨hal-04544439⟩
Aude Guénolé, Fabien Velilla, Aymeric Chartier, April Rich, Anne-Ruxandra Carvunis, et al.. RNF219 regulates CCR4-NOT function in mRNA translation and deadenylation. Scientific Reports, 2022, 12 (1), pp.9288. ⟨10.1038/s41598-022-13309-8⟩. ⟨hal-04275608⟩
Regis Souche, Jean-Michel Fabre. Comment on: “Completion pancreatectomy or a pancreas-preserving procedure during relaparotomy for pancreatic fistula after pancreatoduodenectomy: a multicentre cohort study and meta-analysis”. Hepatobiliary Surgery and Nutrition, 2022, 11 (1), pp.94-96. ⟨10.21037/hbsn-22-2⟩. ⟨hal-04543736⟩
Morgan Michalet, Karl Bordeau, Marie Cantaloube, Simon Valdenaire, Pierre Debuire, et al.. Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study. Frontiers in Oncology, 2022, 12, pp.842402. ⟨10.3389/fonc.2022.842402⟩. ⟨hal-04538122⟩
Esin Orhan, Carolina Velazquez, Imene Tabet, Lise Fenou, Geneviève Rodier, et al.. CDK inhibition results in pharmacologic BRCAness increasing sensitivity to olaparib in BRCA1-WT and olaparib resistant in Triple Negative Breast Cancer. Cancer Letters, 2024, 589, pp.216820. ⟨10.1016/j.canlet.2024.216820⟩. ⟨hal-04535765⟩
Carolina Velazquez, Esin Orhan, Imene Tabet, Lise Fenou, Béatrice Orsetti, et al.. BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib. Frontiers in Oncology, 2023, 13, pp.1125021. ⟨10.3389/fonc.2023.1125021⟩. ⟨hal-04275543⟩
Anna Gueiderikh, Thomas Sarrade, Youlia M. Kirova, Brigitte de la Lande, Florent de Vathaire, et al.. Radiation-induced lung injury after breast cancer treatment: incidence in the CANTO-RT cohort and associated clinical and dosimetric risk factors. Frontiers in Oncology, 2023, 13, ⟨10.3389/fonc.2023.1199043⟩. ⟨hal-04195134⟩
Aurélie Balmer, Daniel Clerc, Laura Toussaint, Olivia Sgarbura, Abdelkader Taïbi, et al.. Selection Criteria for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatment in Patients with Peritoneal Metastases. Cancers, 2022, 14 (10), pp.2557. ⟨10.3390/cancers14102557⟩. ⟨hal-04523177⟩
Jean-Marc Classe, Gilles Dolivet, Serge Evrard, Gwenael Ferron, Fabrice Lécuru, et al.. Recommandations de la Société française de chirurgie oncologique (SFCO) pour l’organisation de la chirurgie oncologique durant l’épidémie de COVID-19. Bulletin du Cancer, 2020, 107 (5), pp.524-527. ⟨10.1016/j.bulcan.2020.03.010⟩. ⟨hal-02988833⟩

Collaborations internationales

Derniers dépôts